LEVALBUTEROL HYDROCHLORIDE
LEVALBUTEROL HYDROCHLORIDE
Approval overview LEVALBUTEROL HYDROCHLORIDE is listed in Drugs@FDA under application 218770 (ANDA).
Review priority: STANDARD Marketing status: Discontinued Active ingredient LEVALBUTEROL HYDROCHLORIDE Form and strength SOLUTION;INHALATION - EQ 0.042% BASE Sponsor MANKIND PHARMA Submission history Latest submission status date: 2024-10-21 00:00:00.
Structured Monograph
Clinical summary
Approval overview LEVALBUTEROL HYDROCHLORIDE is listed in Drugs@FDA under application 218770 (ANDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient LEVALBUTEROL HYDROCHLORIDE Form and strength SOLUTION;INHALATION - EQ 0.042% BASE Sponsor MANKIND PHARMA Submission history Latest submission status date: 2024-10-21 00:00:00. Submission type: ORIG.
Monitoring
- • Marketing status: Discontinued
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.